In perspective: CSL112 (Apolipoprotein A-I) Infusions and Cardiovascular Outcomes in Patients with Acute Myocardial Infarction: the ApoA-I Event Reducing in Ischemic Syndromes II (AEGIS-II) trial.

Published in: European heart journal. Acute cardiovascular care (2024)

Keyphrases